Global Bio Pharma Buffer Market Research Report 2024

Publisher Name :
Date: 08-Jan-2024
No. of pages: 96
Inquire Before Buying

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to The solution, and as a result, The solution resists changes in pH. Solutions with stable pH are required for The processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (

The amount of acid/base that can be added without a change in pH) of a buffer are determined by The conjugate acid-base pair.

Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate The product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in The filtration process for The removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.

The global Bio Pharma Buffer market was valued at US$ 841.4 million in 2023 and is anticipated to reach US$ 1376.7 million by 2030, witnessing a CAGR of 7.2% during The forecast period 2024-2030.

The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to The revenue of these companies, we can know that The Bio Pharma Buffer industry is relative concentrated. Because The top 6 companies have more than 70% market share.

This report aims to provide a comprehensive presentation of The global market for Bio Pharma Buffer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Bio Pharma Buffer.

Report Scope

The Bio Pharma Buffer market size, estimations, and forecasts are provided in terms of sales volume (K Liter) and revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Bio Pharma Buffer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Bio Pharma Buffer manufacturers, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- Avantor

- Alfa Aesar (Thermo Fisher)

- Merck

- Lonza

- Bio-Rad

- BD

- GE Healthcare

- Promega Corporation

- Hamilton Company

- XZL BIO-TECHNOLOGY

- SRL

Segment by Type

- Phosphates Type

- Acetates Type

- TRIS Type

- Others

Segment by Application

- Research Institution

- Pharmaceutical Industry

- Others

Consumption By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (

By Region, by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Detailed analysis of Bio Pharma Buffer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Bio Pharma Buffer in regional level and country level. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and market size of each country in The world.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including The upstream and downstream of The industry.

Chapter 8: Introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by manufacturers in The industry, and The analysis of relevant policies in The industry.

Chapter 9: The main points and conclusions of The report.

Global Bio Pharma Buffer Market Research Report 2024

Table of Contents
1 Bio Pharma Buffer Market Overview
1.1 Product Overview and Scope of Bio Pharma Buffer
1.2 Bio Pharma Buffer Segment by Type
1.2.1 Global Bio Pharma Buffer Market Value Comparison by Type (2024-2030)
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Bio Pharma Buffer Segment by Application
1.3.1 Global Bio Pharma Buffer Market Value by Application: (2024-2030)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Global Bio Pharma Buffer Market Size Estimates and Forecasts
1.4.1 Global Bio Pharma Buffer Revenue 2019-2030
1.4.2 Global Bio Pharma Buffer Sales 2019-2030
1.4.3 Global Bio Pharma Buffer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bio Pharma Buffer Market Competition by Manufacturers
2.1 Global Bio Pharma Buffer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bio Pharma Buffer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bio Pharma Buffer Average Price by Manufacturers (2019-2024)
2.4 Global Bio Pharma Buffer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bio Pharma Buffer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bio Pharma Buffer, Product Type & Application
2.7 Bio Pharma Buffer Market Competitive Situation and Trends
2.7.1 Bio Pharma Buffer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bio Pharma Buffer Players Market Share by Revenue
2.7.3 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bio Pharma Buffer Retrospective Market Scenario by Region
3.1 Global Bio Pharma Buffer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bio Pharma Buffer Global Bio Pharma Buffer Sales by Region: 2019-2030
3.2.1 Global Bio Pharma Buffer Sales by Region: 2019-2024
3.2.2 Global Bio Pharma Buffer Sales by Region: 2025-2030
3.3 Global Bio Pharma Buffer Global Bio Pharma Buffer Revenue by Region: 2019-2030
3.3.1 Global Bio Pharma Buffer Revenue by Region: 2019-2024
3.3.2 Global Bio Pharma Buffer Revenue by Region: 2025-2030
3.4 North America Bio Pharma Buffer Market Facts & Figures by Country
3.4.1 North America Bio Pharma Buffer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bio Pharma Buffer Sales by Country (2019-2030)
3.4.3 North America Bio Pharma Buffer Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bio Pharma Buffer Market Facts & Figures by Country
3.5.1 Europe Bio Pharma Buffer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bio Pharma Buffer Sales by Country (2019-2030)
3.5.3 Europe Bio Pharma Buffer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bio Pharma Buffer Market Facts & Figures by Country
3.6.1 Asia Pacific Bio Pharma Buffer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bio Pharma Buffer Sales by Country (2019-2030)
3.6.3 Asia Pacific Bio Pharma Buffer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bio Pharma Buffer Market Facts & Figures by Country
3.7.1 Latin America Bio Pharma Buffer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bio Pharma Buffer Sales by Country (2019-2030)
3.7.3 Latin America Bio Pharma Buffer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Country
3.8.1 Middle East and Africa Bio Pharma Buffer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bio Pharma Buffer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bio Pharma Buffer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bio Pharma Buffer Sales by Type (2019-2030)
4.1.1 Global Bio Pharma Buffer Sales by Type (2019-2024)
4.1.2 Global Bio Pharma Buffer Sales by Type (2025-2030)
4.1.3 Global Bio Pharma Buffer Sales Market Share by Type (2019-2030)
4.2 Global Bio Pharma Buffer Revenue by Type (2019-2030)
4.2.1 Global Bio Pharma Buffer Revenue by Type (2019-2024)
4.2.2 Global Bio Pharma Buffer Revenue by Type (2025-2030)
4.2.3 Global Bio Pharma Buffer Revenue Market Share by Type (2019-2030)
4.3 Global Bio Pharma Buffer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bio Pharma Buffer Sales by Application (2019-2030)
5.1.1 Global Bio Pharma Buffer Sales by Application (2019-2024)
5.1.2 Global Bio Pharma Buffer Sales by Application (2025-2030)
5.1.3 Global Bio Pharma Buffer Sales Market Share by Application (2019-2030)
5.2 Global Bio Pharma Buffer Revenue by Application (2019-2030)
5.2.1 Global Bio Pharma Buffer Revenue by Application (2019-2024)
5.2.2 Global Bio Pharma Buffer Revenue by Application (2025-2030)
5.2.3 Global Bio Pharma Buffer Revenue Market Share by Application (2019-2030)
5.3 Global Bio Pharma Buffer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Avantor
6.1.1 Avantor Corporation Information
6.1.2 Avantor Description and Business Overview
6.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Avantor Bio Pharma Buffer Product Portfolio
6.1.5 Avantor Recent Developments/Updates
6.2 Alfa Aesar (Thermo Fisher)
6.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
6.2.2 Alfa Aesar (Thermo Fisher) Description and Business Overview
6.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Portfolio
6.2.5 Alfa Aesar (Thermo Fisher) Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Bio Pharma Buffer Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Lonza
6.4.1 Lonza Corporation Information
6.4.2 Lonza Description and Business Overview
6.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lonza Bio Pharma Buffer Product Portfolio
6.4.5 Lonza Recent Developments/Updates
6.5 Bio-Rad
6.5.1 Bio-Rad Corporation Information
6.5.2 Bio-Rad Description and Business Overview
6.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bio-Rad Bio Pharma Buffer Product Portfolio
6.5.5 Bio-Rad Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD Bio Pharma Buffer Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 GE Healthcare
6.6.1 GE Healthcare Corporation Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GE Healthcare Bio Pharma Buffer Product Portfolio
6.7.5 GE Healthcare Recent Developments/Updates
6.8 Promega Corporation
6.8.1 Promega Corporation Corporation Information
6.8.2 Promega Corporation Description and Business Overview
6.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Promega Corporation Bio Pharma Buffer Product Portfolio
6.8.5 Promega Corporation Recent Developments/Updates
6.9 Hamilton Company
6.9.1 Hamilton Company Corporation Information
6.9.2 Hamilton Company Description and Business Overview
6.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hamilton Company Bio Pharma Buffer Product Portfolio
6.9.5 Hamilton Company Recent Developments/Updates
6.10 XZL BIO-TECHNOLOGY
6.10.1 XZL BIO-TECHNOLOGY Corporation Information
6.10.2 XZL BIO-TECHNOLOGY Description and Business Overview
6.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Portfolio
6.10.5 XZL BIO-TECHNOLOGY Recent Developments/Updates
6.11 SRL
6.11.1 SRL Corporation Information
6.11.2 SRL Bio Pharma Buffer Description and Business Overview
6.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
6.11.4 SRL Bio Pharma Buffer Product Portfolio
6.11.5 SRL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bio Pharma Buffer Industry Chain Analysis
7.2 Bio Pharma Buffer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bio Pharma Buffer Production Mode & Process
7.4 Bio Pharma Buffer Sales and Marketing
7.4.1 Bio Pharma Buffer Sales Channels
7.4.2 Bio Pharma Buffer Distributors
7.5 Bio Pharma Buffer Customers
8 Bio Pharma Buffer Market Dynamics
8.1 Bio Pharma Buffer Industry Trends
8.2 Bio Pharma Buffer Market Drivers
8.3 Bio Pharma Buffer Market Challenges
8.4 Bio Pharma Buffer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Bio Pharma Buffer Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bio Pharma Buffer Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Bio Pharma Buffer Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bio Pharma Buffer Sales (K Liter) of Key Manufacturers (2019-2024)
Table 5. Global Bio Pharma Buffer Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bio Pharma Buffer Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bio Pharma Buffer Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bio Pharma Buffer Average Price (USD/Liter) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bio Pharma Buffer, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bio Pharma Buffer, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bio Pharma Buffer, Product Type & Application
Table 12. Global Key Manufacturers of Bio Pharma Buffer, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Pharma Buffer as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bio Pharma Buffer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bio Pharma Buffer Sales by Region (2019-2024) & (K Liter)
Table 18. Global Bio Pharma Buffer Sales Market Share by Region (2019-2024)
Table 19. Global Bio Pharma Buffer Sales by Region (2025-2030) & (K Liter)
Table 20. Global Bio Pharma Buffer Sales Market Share by Region (2025-2030)
Table 21. Global Bio Pharma Buffer Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bio Pharma Buffer Revenue Market Share by Region (2019-2024)
Table 23. Global Bio Pharma Buffer Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bio Pharma Buffer Revenue Market Share by Region (2025-2030)
Table 25. North America Bio Pharma Buffer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
Table 27. North America Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
Table 28. North America Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bio Pharma Buffer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
Table 32. Europe Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
Table 33. Europe Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bio Pharma Buffer Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bio Pharma Buffer Sales by Region (2019-2024) & (K Liter)
Table 37. Asia Pacific Bio Pharma Buffer Sales by Region (2025-2030) & (K Liter)
Table 38. Asia Pacific Bio Pharma Buffer Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bio Pharma Buffer Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bio Pharma Buffer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
Table 42. Latin America Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
Table 43. Latin America Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Bio Pharma Buffer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
Table 47. Middle East & Africa Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
Table 48. Middle East & Africa Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bio Pharma Buffer Sales (K Liter) by Type (2019-2024)
Table 51. Global Bio Pharma Buffer Sales (K Liter) by Type (2025-2030)
Table 52. Global Bio Pharma Buffer Sales Market Share by Type (2019-2024)
Table 53. Global Bio Pharma Buffer Sales Market Share by Type (2025-2030)
Table 54. Global Bio Pharma Buffer Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bio Pharma Buffer Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bio Pharma Buffer Revenue Market Share by Type (2019-2024)
Table 57. Global Bio Pharma Buffer Revenue Market Share by Type (2025-2030)
Table 58. Global Bio Pharma Buffer Price (USD/Liter) by Type (2019-2024)
Table 59. Global Bio Pharma Buffer Price (USD/Liter) by Type (2025-2030)
Table 60. Global Bio Pharma Buffer Sales (K Liter) by Application (2019-2024)
Table 61. Global Bio Pharma Buffer Sales (K Liter) by Application (2025-2030)
Table 62. Global Bio Pharma Buffer Sales Market Share by Application (2019-2024)
Table 63. Global Bio Pharma Buffer Sales Market Share by Application (2025-2030)
Table 64. Global Bio Pharma Buffer Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bio Pharma Buffer Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bio Pharma Buffer Revenue Market Share by Application (2019-2024)
Table 67. Global Bio Pharma Buffer Revenue Market Share by Application (2025-2030)
Table 68. Global Bio Pharma Buffer Price (USD/Liter) by Application (2019-2024)
Table 69. Global Bio Pharma Buffer Price (USD/Liter) by Application (2025-2030)
Table 70. Avantor Corporation Information
Table 71. Avantor Description and Business Overview
Table 72. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 73. Avantor Bio Pharma Buffer Product
Table 74. Avantor Recent Developments/Updates
Table 75. Alfa Aesar (Thermo Fisher) Corporation Information
Table 76. Alfa Aesar (Thermo Fisher) Description and Business Overview
Table 77. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 78. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product
Table 79. Alfa Aesar (Thermo Fisher) Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 83. Merck Bio Pharma Buffer Product
Table 84. Merck Recent Developments/Updates
Table 85. Lonza Corporation Information
Table 86. Lonza Description and Business Overview
Table 87. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 88. Lonza Bio Pharma Buffer Product
Table 89. Lonza Recent Developments/Updates
Table 90. Bio-Rad Corporation Information
Table 91. Bio-Rad Description and Business Overview
Table 92. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 93. Bio-Rad Bio Pharma Buffer Product
Table 94. Bio-Rad Recent Developments/Updates
Table 95. BD Corporation Information
Table 96. BD Description and Business Overview
Table 97. BD Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 98. BD Bio Pharma Buffer Product
Table 99. BD Recent Developments/Updates
Table 100. GE Healthcare Corporation Information
Table 101. GE Healthcare Description and Business Overview
Table 102. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 103. GE Healthcare Bio Pharma Buffer Product
Table 104. GE Healthcare Recent Developments/Updates
Table 105. Promega Corporation Corporation Information
Table 106. Promega Corporation Description and Business Overview
Table 107. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 108. Promega Corporation Bio Pharma Buffer Product
Table 109. Promega Corporation Recent Developments/Updates
Table 110. Hamilton Company Corporation Information
Table 111. Hamilton Company Description and Business Overview
Table 112. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 113. Hamilton Company Bio Pharma Buffer Product
Table 114. Hamilton Company Recent Developments/Updates
Table 115. XZL BIO-TECHNOLOGY Corporation Information
Table 116. XZL BIO-TECHNOLOGY Description and Business Overview
Table 117. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 118. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product
Table 119. XZL BIO-TECHNOLOGY Recent Developments/Updates
Table 120. SRL Corporation Information
Table 121. SRL Description and Business Overview
Table 122. SRL Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 123. SRL Bio Pharma Buffer Product
Table 124. SRL Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Bio Pharma Buffer Distributors List
Table 128. Bio Pharma Buffer Customers List
Table 129. Bio Pharma Buffer Market Trends
Table 130. Bio Pharma Buffer Market Drivers
Table 131. Bio Pharma Buffer Market Challenges
Table 132. Bio Pharma Buffer Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bio Pharma Buffer
Figure 2. Global Bio Pharma Buffer Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bio Pharma Buffer Market Share by Type in 2023 & 2030
Figure 4. Phosphates Type Product Picture
Figure 5. Acetates Type Product Picture
Figure 6. TRIS Type Product Picture
Figure 7. Others Product Picture
Figure 8. Global Bio Pharma Buffer Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Bio Pharma Buffer Market Share by Application in 2023 & 2030
Figure 10. Research Institution
Figure 11. Pharmaceutical Industry
Figure 12. Others
Figure 13. Global Bio Pharma Buffer Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Bio Pharma Buffer Market Size (2019-2030) & (US$ Million)
Figure 15. Global Bio Pharma Buffer Sales (2019-2030) & (K Liter)
Figure 16. Global Bio Pharma Buffer Average Price (USD/Liter) & (2019-2030)
Figure 17. Bio Pharma Buffer Report Years Considered
Figure 18. Bio Pharma Buffer Sales Share by Manufacturers in 2023
Figure 19. Global Bio Pharma Buffer Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Bio Pharma Buffer Players: Market Share by Revenue in 2023
Figure 21. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Bio Pharma Buffer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Bio Pharma Buffer Sales Market Share by Country (2019-2030)
Figure 24. North America Bio Pharma Buffer Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Bio Pharma Buffer Sales Market Share by Country (2019-2030)
Figure 28. Europe Bio Pharma Buffer Revenue Market Share by Country (2019-2030)
Figure 29. Germany Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Bio Pharma Buffer Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region (2019-2030)
Figure 36. China Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Bio Pharma Buffer Sales Market Share by Country (2019-2030)
Figure 47. Latin America Bio Pharma Buffer Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Bio Pharma Buffer Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Bio Pharma Buffer Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Bio Pharma Buffer Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Bio Pharma Buffer by Type (2019-2030)
Figure 57. Global Revenue Market Share of Bio Pharma Buffer by Type (2019-2030)
Figure 58. Global Bio Pharma Buffer Price (USD/Liter) by Type (2019-2030)
Figure 59. Global Sales Market Share of Bio Pharma Buffer by Application (2019-2030)
Figure 60. Global Revenue Market Share of Bio Pharma Buffer by Application (2019-2030)
Figure 61. Global Bio Pharma Buffer Price (USD/Liter) by Application (2019-2030)
Figure 62. Bio Pharma Buffer Value Chain
Figure 63. Bio Pharma Buffer Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs